PBYI: Puma Biotechnology Inc Stock Price Quote - NASDAQ GS - Bloomberg
Alan H. Auerbach Net Worth (2023) | wallmine
Puma Biotechnology - Overview, News & Competitors | ZoomInfo.com
Puma Biotech victory in neratinib litigation
Neratinib Improves PFS in HER2+ Metastatic Breast Cancer
Alan Auerbach: Puma Biotech's Overnight Billionaire - Forbes India
Puma Biotechnology CEO And Leadership: Executives and Demographics - Zippia
Barry Simon vs Alan Auerbach | Comparably
DEFA14A
Alan Auerbach
Alan Auerbach email address & phone number | Puma Biotechnology, Inc Chief Executive Officer, President contact information - RocketReach
Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Alan AUERBACH | CEO | Puma Biotechnology, Inc, California | Corporate | Research profile
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Local Executive Pay Experiences Recovery - Los Angeles Business Journal
Part 2: Alan Auerbach President & CEO Puma Biotech - YouTube
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Alan H. Auerbach - Los Angeles Business Journal
Puma Biotechnology Executive Salaries | Comparably
Biotech Entrepreneur's Fortune Nearly Doubles After Strong Clinical Trials For Cancer Treatment
Puma Back Up on FDA OK - Los Angeles Business Journal
